Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amsal Chem is a prominent Indian pharmaceutical company specializing in the manufacture and export of Active Pharmaceutical Ingredients (APIs) and bulk drugs. Founded in 1981, the company has established itself as a key global supplier of antimalarial medications, including Chloroquine Phosphate, Amodiaquine Hydrochloride, and Primaquine Phosphate. The company operates a state-of-the-art manufacturing facility in Ankleshwar, Gujarat, which is WHO-GMP certified. Amsal Chem serves a wide range of international markets, providing essential medicines to healthcare systems in Africa, Southeast Asia, and Latin America. In addition to antimalarials, their portfolio includes treatments for cardiovascular conditions and gastrointestinal disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amsal Chem.